NCT06714617 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06714617
Title	Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	SystImmune Inc.
Indications	gastroesophageal junction adenocarcinoma Her2-receptor positive breast cancer transitional cell carcinoma fallopian tube cancer peritoneum cancer ovarian cancer Advanced Solid Tumor stomach cancer endometrial cancer lung non-small cell carcinoma
Therapies	BL-M17D1
Age Groups:	adult \| senior
Covered Countries	USA

NCT06714617
Clinical Trial Detail